Key Concepts
Adoption of AI in healthcare, rule-based algorithms, generative AI, FDA-approved AI tools, workflow integration, platform technologies, interoperability, consumerization of healthcare, longitudinal patient data, human-machine interface, precision medicine, information asymmetry, genome-wide association studies, drug development, clinical trials, real-time data monitoring, regulatory submissions.
Adoption and Use Cases of AI Models
The adoption of AI models continues to rise, with sustained downloads and an increasing user base. There's a range of use cases and user groups, from basic tasks like email writing to creative ideation. A key point is using the "right tool for the right fit," like a calculator for simple math versus AI for brainstorming.
Examples:
- Traditional Use Cases: Writing letters or emails, translation.
- Creative Use Cases: Brainstorming ideas for a talk.
AI in Medical Practice: Three Categories
Dr. Mega outlines three categories for AI application in medical practice:
-
Rules-Based Algorithms: For tasks like drug-drug interactions and risk scoring before surgery. These are well-established and require no deviation from agreed-upon rules.
-
FDA-Approved AI Tools: Predominantly in cardiology and radiology. These tools focus on discrete tasks with deep learning and multiple training sets. Acceptance is high when safety, effectiveness, and value are demonstrated.
- Example: Using fundus images to triage diabetic patients for care; these models can outperform individual readers. Over 220 such tools are approved.
-
Generative AI: Applied at both ends of the spectrum, from understanding biology and drug development to delivering patient information effectively. It emphasizes creativity and pattern prediction.
The Agent Space and Workflow Integration
Matt Lungren raises the question of integrating various AI tools into a unified interface rather than using multiple separate applications. He suggests an "agentspace" where a single model understands user intent and accesses specialized tools as needed, acting as a co-pilot or companion. Dr. Mega agrees that workflow integration is crucial, citing scribe technology as an example where embedding tools into daily routines increases adoption. The goal is to create seamless platforms that avoid requiring users to log into numerous portals.
Consumerization of Healthcare and Longitudinal Data
Dr. Mega emphasizes putting the individual at the center of their healthcare journey and creating tools that follow them longitudinally. She highlights the importance of continuous understanding of information and action.
Example: Using continuous glucose monitors (CGM) to provide personalized insights and empower patients with diabetes. Verily partnered with Dexcom to develop CGMs that are easier to use and provide real-time data, and a clinical trial showed reduced hemoglobin A1c levels.
- Data Points: Patients are already inputting medical data into consumer-facing models and having long conversations about their health decisions. A Reddit thread example illustrated how a model's diagnosis differed from a hospital's, which was later confirmed. 5-10% of ChatGPT queries are health-related.
The Future of the Care Team and Actionable Information
Dr. Mega envisions a future where AI tools provide reliable information, enabling healthcare professionals to become "action agents." She draws a parallel to the adoption of cell counters, which are now trusted without question. However, she acknowledges that the accuracy of information from generative AI varies, necessitating careful validation. She suggests that the stethoscope or MRI scanner were once considered disruptive technologies.
She also highlights the need to contextualize health data within the broader context of an individual's life, considering factors beyond traditional medical information. Precision health considers the longitudinal journey that individuals are on, whether with diabetes or a cancer diagnosis. This necessitates interoperability to follow the patient’s journey.
Genomics and Personalized Medicine Parallels
Dr. Mega draws parallels between the early days of genomics and the current AI revolution. She recalls challenges with replicating association studies and the need for robust statistical methods. Similar to the advancements in compute power that facilitated genomics research, AI benefits from increased computational capabilities. Lessons learned from genomics, such as the importance of replication and validation, are applicable to AI. She sees the field of biology moving towards incorporating "laws" similar to those in physics, aided by AI tools.
Drug Development and Clinical Trials
AI can accelerate drug discovery by identifying new targets and intelligently driving small molecule development. Dr. Mega acknowledges the need to improve the efficiency of clinical trials, including patient recruitment, data monitoring, and regulatory submissions. However, she emphasizes the importance of clinical trials for real testing of biology and suggests tools to make the processes more efficient.
Three to Five Year Outlook
Dr. Mega predicts a better understanding of where AI information is most useful and actionable. She envisions streamlined clinical tasks, giving healthcare professionals more time for complex decision-making and patient interaction. Data trustworthiness is essential for adoption and new advancements. She emphasizes that using the right tools in the right context is the way forward.
Synthesis/Conclusion
The adoption of AI in healthcare is rapidly evolving, with applications ranging from simple rule-based tasks to complex generative processes. Key to successful integration is workflow incorporation, interoperability, and a focus on actionable information that empowers both healthcare providers and patients. Drawing parallels with the evolution of genomics, the discussion emphasizes the need for rigorous validation, ethical considerations, and a commitment to improving the healthcare experience for individuals. The future involves a shift towards platform technologies, longitudinal data, and a leveling of information asymmetry between patients and physicians, paving the way for more personalized and effective care.
AI summaries can miss context or contain errors. Check important details against the original video.